| 1. |
- Thomas, HS, et al.
(författare)
-
- 2019
-
swepub:Mat__t
|
|
| 2. |
- Kanai, M, et al.
(författare)
-
- 2023
-
swepub:Mat__t
|
|
| 3. |
|
|
| 4. |
- Gonzalez, Jose M., et al.
(författare)
-
Spatial and sectoral benefit distribution in water-energy system design
- 2020
-
Ingår i: Applied Energy. - : Elsevier BV. - 0306-2619 .- 1872-9118. ; 269
-
Tidskriftsartikel (refereegranskat)abstract
- The design of water and energy systems has traditionally been done independently or considering simplified interdependencies between the two systems. This potentially misses valuable synergies between them and does not consider in detail the distribution of benefits between different sectors or regions. This paper presents a framework to couple integrated water-power network simulators with multi-objective optimisation under uncertainty to explore the implications of explicitly including spatial topology and interdependencies in the design of multi-sector integrated systems. A synthetic case study that incorporates sectoral dependencies in resource allocation, operation of multi-purpose reservoirs and spatially distributed infrastructure selection in both systems is used. The importance of explicitly modelling the distribution of benefits across different sectors and regions is explored by comparing different spatially aggregated and disaggregated multi-objective optimisation formulations. The results show the disaggregated formulation identifies a diverse set of non-dominated portfolios that enables addressing the spatial and sectoral distribution of benefits, whilst the aggregated formulations arbitrarily induce unintended biases. The proposed disaggregated approach allows for detailed spatial design of interlinked water and energy systems considering their complex regional and sectoral trade-offs. The framework is intended to assist planners in real resource systems where diverse stakeholder groups are mindful of receiving their fair share of development benefits.
|
|
| 5. |
|
|
| 6. |
- Borras, J. M., et al.
(författare)
-
Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink
- 2022
-
Ingår i: Radiotherapy and Oncology. - : Elsevier BV. - 0167-8140. ; 169, s. 114-123
-
Forskningsöversikt (refereegranskat)abstract
- Background and purpose: Complex surgery and radiotherapy are the central pillars of loco-regional oncology treatment. This paper describes the reimbursement schemes used in radiation and complex surgical oncology, reports on literature and policy reviews. Material and methods: A systematic review of the literature of the reimbursement models has been carried out separately for radiotherapy and complex cancer surgery based on PRISMA guidelines. Using searches of PubMed and grey literature, we identified articles from scientific journals and reports published since 2000 on provider payment or reimbursement systems currently used in radiation oncology and complex cancer surgery, also including policy models. Results: Most European health systems reimburse radiotherapy using a budget-based, fee-for-service or fraction-based system; while few reimburse services according to an episode-based model. Also, the reimbursement models for cancer surgery are mostly restricted to differences embedded in the DRG system and adjustments applied to the fees, based on the complexity of each surgical procedure. There is an enormous variability in reimbursement across countries, resulting in different incentives and different amounts paid for the same therapeutic strategy. Conclusion: A reimbursement policy, based on the episode of care as the basic payment unit, is advocated for. Innovation should be tackled in a two-tier approach: one defining the common criteria for reimbursement of proven evidence-based interventions; another for financing emerging innovation with uncertain definitive value. Relevant clinical and economic data, also collected real-life, should support reimbursement systems that mirror the actual cost of evidence-based practice.
|
|
| 7. |
- Borras, Josep M, et al.
(författare)
-
Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink.
- 2022
-
Ingår i: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. - : Elsevier BV. - 1532-2157. ; 48:5, s. 967-977
-
Forskningsöversikt (refereegranskat)abstract
- Complex surgery and radiotherapy are the central pillars of loco-regional oncology treatment. This paper describes the reimbursement schemes used in radiation and complex surgical oncology, reports on literature and policy reviews.A systematic review of the literature of the reimbursement models has been carried out separately for radiotherapy and complex cancer surgery based on PRISMA guidelines. Using searches of PubMed and grey literature, we identified articles from scientific journals and reports published since 2000 on provider payment or reimbursement systems currently used in radiation oncology and complex cancer surgery, also including policy models.Most European health systems reimburse radiotherapy using a budget-based, fee-for-service or fraction-based system; while few reimburse services according to an episode-based model. Also, the reimbursement models for cancer surgery are mostly restricted to differences embedded in the DRG system and adjustments applied to the fees, based on the complexity of each surgical procedure. There is an enormous variability in reimbursement across countries, resulting in different incentives and different amounts paid for the same therapeutic strategy.A reimbursement policy, based on the episode of care as the basic payment unit, is advocated for. Innovation should be tackled in a two-tier approach: one defining the common criteria for reimbursement of proven evidence-based interventions; another for financing emerging innovation with uncertain definitive value. Relevant clinical and economic data, also collected real-life, should support reimbursement systems that mirror the actual cost of evidence-based practice.
|
|
